Related Experiment Videos
Synovial fluid total hemolytic complement activity in rheumatic diseases - a reappraisal
The Journal of Rheumatology
|May 1, 1981
Summary
Measuring total hemolytic complement activity in synovial fluid offers limited value for diagnosing or predicting the outcome of joint diseases. This analysis suggests it is not a reliable indicator for assessing drug therapy effectiveness in rheumatic conditions.
Area of Science:
- Rheumatology
- Immunology
- Clinical Chemistry
Background:
- Contradictory claims exist regarding the clinical utility of total hemolytic complement activity measurements in rheumatic diseases.
- Assay anomalies and the semi-quantitative nature of complement activity testing complicate interpretation.
Purpose of the Study:
- To reappraise the role of total hemolytic complement activity measurements in rheumatic diseases.
- To review the literature concerning the diagnostic and prognostic value of synovial fluid complement levels.
Main Methods:
- Literature review focusing on studies measuring total hemolytic complement activity in synovial fluid.
- Analysis of the relationship between synovial fluid complement activity and disease diagnosis, prognosis, and clinical markers.
Main Results:
- Synovial fluid total hemolytic complement activity measurements have limited diagnostic and prognostic value in joint diseases.
- No significant correlation was found between synovial fluid complement activity and clinical disease activity or other laboratory findings.
Conclusions:
- Measurements of synovial fluid complement activity are of limited utility for diagnosing or predicting the course of joint diseases.
- Synovial fluid complement activity is unlikely to be a useful guide for evaluating the efficacy of drug therapies in rheumatic conditions.